Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 91.19% | 60.90% | 53.46% | 83.06% | 48.25% |
| Total Depreciation and Amortization | 2.44% | -55.22% | -56.25% | -11.11% | -38.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -419.04% | -166.19% | -147.90% | -149.67% | -77.79% |
| Change in Net Operating Assets | -32.06% | 413.33% | 533.12% | 288.24% | 213.56% |
| Cash from Operations | -14.62% | -15.35% | 5.94% | 9.12% | 30.92% |
| Capital Expenditure | 20.00% | 20.00% | -- | -50.00% | -15.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 20.00% | 20.00% | -- | -107.50% | -107.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00% | 1.28% | 35.48% | 31.27% | 32.11% |
| Issuance of Common Stock | 15.21% | -20.65% | -85.53% | 164.08% | 191.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.81% | -17.23% | -78.53% | 220.24% | 276.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.37% | -384.28% | -11,635.29% | 83.69% | 88.52% |